Adjuncts for the evaluation of Potentially Malignant disorders of Oral cavity - Dr Rahul Singh

Value of the Information & Strength of the Argument

The presentation provides a valuable and comprehensive overview of adjuncts for OPMD evaluation, systematically covering a wide range of techniques with their mechanisms, procedures, and diagnostic performance metrics. The speaker effectively organizes the content into three main categories, making it easy to follow. The argumentation is generally solid, with the speaker explaining the rationale behind each adjunct and citing sensitivity/specificity values. However, the presentation lacks critical appraisal of the evidence; for instance, the speaker does not discuss the quality of studies or potential biases. The discussion with senior clinicians adds valuable perspective on evidence-based recommendations and implementability, which strengthens the overall argumentation by highlighting practical considerations. The speaker also correctly emphasizes that these adjuncts are not replacements for the gold standard of visual inspection, palpation, and biopsy.

Scientific Rigor, Source Quality, Title Accuracy

The presentation demonstrates a good level of scientific rigor, with the speaker referencing WHO terminology and presenting data on sensitivity and specificity for each adjunct. However, specific sources are not cited within the talk, and the reference list at the end is not detailed enough for verification. The title accurately reflects the content, which is focused on adjuncts for OPMD evaluation. The discussion with senior clinicians adds a layer of critical evaluation, emphasizing the need for evidence-based recommendations and implementability, which is a strength. However, the lack of systematic evidence synthesis (e.g., Cochrane reviews) and the absence of specific citations limit the scientific rigor. The presentation is suitable for a professional audience, but the speaker could have strengthened the content by including more robust evidence and discussing limitations more thoroughly.

The title accurately reflects the content, which focuses on adjuncts for evaluating oral potentially malignant disorders.

7/10

The presentation is a comprehensive expert review of adjuncts for evaluating oral potentially malignant disorders, covering vital staining, cytology, and various optical imaging techniques. The speaker demonstrates good knowledge of the field, citing WHO terminology and presenting sensitivity/specificity data for each modality. However, the talk lacks systematic evidence synthesis (e.g., Cochrane reviews) and does not provide specific citations for the data presented, limiting verifiability. The discussion with senior clinicians adds practical perspective on implementability and evidence-based recommendations.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and welcome by Dr. Poonam Joshi
• 01:00Definition of OPMDs and shift from 'precancerous lesions' to 'disorders'
• 03:00Epidemiology and malignant transformation rates of OPMDs
• 05:00Introduction to three main adjuncts: vital staining, cytology, visualization
• 07:00Vital staining: toluidine blue, Lugol's iodine, methylene blue, rose bengal
• 10:00Oral cytology: exfoliative, transepithelial, FNA; advantages and disadvantages
• 15:00Visualization adjuncts: chemiluminescence and autofluorescence imaging
• 20:00Narrow band imaging, confocal microscopy, high-resolution microendoscopy
• 25:00Spectroscopic techniques: elastic scattering, diffuse reflectance, Raman, fluorescence
• 30:00Optical coherence tomography and predictive biomarkers in blood and saliva
• 35:00Discussion and comments from senior clinicians on evidence and implementability

• WHO definition of oral potentially malignant disorders — Mentioned as the origin of the term OPMD in 2005

• Oral potentially malignant disorders: A comprehensive review — Provides background on OPMDs and their management, aligning with the presentation's content.

• Cochrane review on screening for oral cancer — The presentation did not include systematic evidence-based recommendations, which the senior clinician noted as a missing component.